These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 18789365

  • 1. Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development.
    Smeesters PR, Mardulyn P, Vergison A, Leplae R, Van Melderen L.
    Vaccine; 2008 Oct 29; 26(46):5835-42. PubMed ID: 18789365
    [Abstract] [Full Text] [Related]

  • 2. The emm-type diversity does not always reflect the M protein genetic diversity--is there a case for designer vaccine against GAS.
    Smeesters PR, Dramaix M, Van Melderen L.
    Vaccine; 2010 Jan 22; 28(4):883-5. PubMed ID: 19963033
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
    Yoonim N, Olive C, Pruksachatkunakorn C, Pruksakorn S.
    BMC Microbiol; 2006 Aug 09; 6():71. PubMed ID: 16895610
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns.
    Tewodros W, Kronvall G.
    J Clin Microbiol; 2005 Sep 09; 43(9):4369-76. PubMed ID: 16145079
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Group A streptococcal infections: trend and strain emm typing in an area of central Italy, 1985-2002.
    Mencarelli M, Corbisiero R, Padula MG, Galgani I, Stolzuoli L, Cellesi C.
    Epidemiol Infect; 2005 Dec 09; 133(6):1107-11. PubMed ID: 16274508
    [Abstract] [Full Text] [Related]

  • 10. Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci.
    Good MF, Pandey M, Batzloff MR, Tyrrell GJ.
    Expert Rev Vaccines; 2015 Dec 09; 14(11):1459-70. PubMed ID: 26485214
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries.
    Sakota V, Fry AM, Lietman TM, Facklam RR, Li Z, Beall B.
    J Clin Microbiol; 2006 Jun 09; 44(6):2160-6. PubMed ID: 16757615
    [Abstract] [Full Text] [Related]

  • 15. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002.
    Shulman ST, Tanz RR, Kabat W, Kabat K, Cederlund E, Patel D, Li Z, Sakota V, Dale JB, Beall B, US Streptococcal Pharyngitis Surveillance Group.
    Clin Infect Dis; 2004 Aug 01; 39(3):325-32. PubMed ID: 15306998
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides.
    Olive C, Hsien K, Horváth A, Clair T, Yarwood P, Toth I, Good MF.
    Vaccine; 2005 Mar 18; 23(17-18):2298-303. PubMed ID: 15755615
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lipid core peptide technology and group A streptococcal vaccine delivery.
    Olive C, Batzloff MR, Toth I.
    Expert Rev Vaccines; 2004 Feb 18; 3(1):43-58. PubMed ID: 14761243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.